Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

Long Covid

Financiado

Cerrado

Decision support for prediction and management of Long Covid Syndrome (LCS)

We will develop tools and knowledge to support physicians in accurately managing Long COVID syndrome (LCS) which has a significant impact on sufferers as well as their surroundings. Although much is now known regarding appropriate... ver más

31/05/2026

HUS

7M€

Presupuesto del proyecto: 7M€

Líder del proyecto

HUSYHTYMA No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Ver 14 Participantes

Financiación concedida El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2022-05-23

HORIZON-HLTH-2021-DISEASE-04-07: Personalised medicine and infectiou... ExpectedOutcome:This topic aims at supporting activities that are enabling or contributing to one or...

I+D

Cerrada hace 3 años

0% 100% 100%

Características del participante

Este proyecto no cuenta con búsquedas de partenariado abiertas en este momento.

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

14 Participantes

HUS

1.41M€ | Lider

HELSINGIN YLIOPISTO

1.05M€ | Participante

UNIVERSITAT BASEL

N.D. | Participante

Proyectos interesantes

END-VOC

Medical Technol...

Data Science

10M€ Cerrado

REACT

Medical Technol...

Data Science

8M€ Cerrado

HEDIMED

Medical Technol...

Data Science

12M€ Cerrado

CoVICIS

Medical Technol...

Data Science

10M€ Cerrado

BEATsep

Medical Technol...

Data Science

7M€ Cerrado

UNDINE

Medical Technol...

Data Science

7M€ Cerrado

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Duración del proyecto: 48 meses Fecha Inicio: 2022-05-23
Fecha Fin: 2026-05-31

Líder del proyecto

HUSYHTYMA No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 7M€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto We will develop tools and knowledge to support physicians in accurately managing Long COVID syndrome (LCS) which has a significant impact on sufferers as well as their surroundings. Although much is now known regarding appropriate clinical management of acute COVID-19, very little is known about clinical manifestations, risk factors and underlying mechanisms for development of the highly heterogenous LCS. In this project, we aim to understand and mechanisms of LCS by combining front-line expertise from the fields of clinical medicine, virology, metabolism and immunology. We will study the pathogenesis of LCS by conducting geographically diverse cohort and registry studies, by conducting mechanistic studies, by using novel high-throughput methods for biomarker analysis, and by conducting interventional and follow-up studies on LCS patients. We will combine results from clinical and mechanistic studies to identify molecular and physiological parameters and/or pathways to decipher the mechanisms underlying LCS. We will exploit the high-throughput omics technologies to identify the predisposing factors and biomarkers that lead to the development of LCS. We will collect data from the cohort, mechanistic, biomarker and interventional studies and use these to validate the predictive artificial intelligence algorithms and to produce information and gain understanding on the combination of factors that lead to certain clustering of patients into different groups with specific symptoms. A machine learning and AI-informed Long Covid Prediction Support (LCPS) tool will be developed for the use of clinicians to predict the LCS and its possible clinical manifestations in patients. It will also help in the choice of personalized treatments for LCS patients. Additionally, an interactive graphic user interface infographic will also be available to clinicians and patients; this will communicate novel and understandable information about LCS and recommendations for patient management.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores